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Abstract
Aim The worldwide prevalence of type 2 diabetes mellitus is increasing, with most individuals with the disease being
overweight or obese. Weight loss can reduce disease-related morbidity and mortality and weight losses of 10–15 kg have
been shown to reverse type 2 diabetes. This review aimed to determine the effectiveness of community-based educational
interventions for weight loss in type 2 diabetes.
Methods This is a systematic review and meta-analysis of randomized controlled trials (RCT) in obese or overweight
adults, aged 18–75 years, with a diagnosis of type 2 diabetes. Primary outcomes were weight and/or BMI. CINAHL,
MEDLINE, Embase, Scopus and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from
inception to June 2019. Trials were classified into specified a priori comparisons according to intervention type. A pooled
standardized mean difference (SMD) (from baseline to follow-up) and 95% confidence intervals (95% CI) between trial
groups (difference-in-difference) were estimated through random-effects meta-analyses using the inverse variance
method. Heterogeneity was quantified using I2 and publication bias was explored visually using funnel plots.
Results Some 7383 records were screened; 228 full-text articles were assessed and 49 RCTs (n = 12 461 participants)
were included in this review, with 44 being suitable for inclusion into the meta-analysis. Pooled estimates of education
combined with low-calorie, low-carbohydrate meal replacements (SMD = –2.48, 95% CI –3.59, –1.49, I2 = 98%) or
diets (SMD = –1.25, 95% CI –2.11, –0.39, I2 = 95%) or low-fat meal replacements (SMD = –1.15, 95%CI –2.05, –
1.09, I2 = 85%) appeared most effective.
Conclusion Low-calorie, low-carbohydrate meal replacements or diets combined with education appear the most
promising interventions to achieve the largest weight and BMI reductions in people with type 2 diabetes.
Diabet. Med. 00, 1–13 (2019)
Introduction
By 2030, it is estimated that approximately half of the world’s
adult population will be overweight (BMI 25–29.9 kg/m2) or
obese (BMI > 30 kg/m2) [1]. Obesity is associated with the
development of type 2 diabetes, with figures estimating that
85–90% of people with type 2 diabetes are overweight or
obese [2]. Diabetes prevalence is predicted to rise to
693 million worldwide by 2045 [3]. As BMI increases, the
associated medical costs of managing type 2 diabetes increase
[4]. With an estimated global economic burden of US $2.5
trillion or 2.2% of gross domestic product by 2030 [5].
Weight loss in type 2 diabetes improves metabolic control
and reduces the risk of complications [6], while significant
weight losses of 10–15 kg have been seen to reverse diabetes
[7]. Traditionally, low-carbohydrate diets have been advo-
cated for weight loss in type 2 diabetes; however, evidence
for the effects on long-term health is conflicting [8–10].
Weight loss is more difficult for people with diabetes, who
lose approximately half the amount of weight compared to
people without diabetes undergoing the same intervention
[11]; this is compounded by certain anti-diabetic medications
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causing weight gain [12,13]. In people with type 2 diabetes,
weight loss is often regained within 1 year of being lost [14],
with a return to baseline weight frequently seen within 3–
5 years [15]. Bariatric surgery appears to be a cost-effective
intervention for obesity and is associated with weight losses
of up to 30% at 1 year (reducing to 24% by 5 years) and
reversal of type 2 diabetes [16]. However, access to surgery is
restricted [17], resource intensive, often requires lifelong
supplementation and may not be a preferred choice for obese
individuals [18]. Lifestyle interventions which can achieve
sustained weight loss in type 2 diabetes are therefore needed.
Previous systematic reviews of weight loss interventions in
people with type 2 diabetes are now either outdated [19–21],
included participants with a normal BMI [20], included only
interventions of > 12 months’ duration [19] or searched a
limited number of databases [19]. We have therefore
undertaken a systematic review to determine the effectiveness
of community-based educational interventions, of any dura-
tion and follow-up, in achieving weight loss in overweight
and obese adults aged 18–75 years with type 2 diabetes. A
secondary aim was to investigate whether weight loss was
sustained after the intervention in trials with a maintenance
component.
Research design and methods
A detailed description of the study methods is provided in the
registered protocol [22].Given the large number of studies and
number of potential secondary outcomes, this review focused
on the primary outcomes of weight and BMI change only.
Information sources
MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCO), the
Cochrane Central Register of Controlled Trials (CENTRAL)
and Scopus were searched from inception to June 2019, with
no language restrictions. The reference lists of included trials
were also searched. The grey literature was not searched.
Search strategy
The search strategy used comprised of type 2 diabetes mellitus
or type 2 diabetes or t2dm AND overweight or obesity or
obeseANDeducationANDweight loss orweight reduction or
lose weight. However, the search strategy varied for each
database. The Cochrane Highly Sensitive Search Strategy for
identifying randomized trials was used in MEDLINE: sensi-
tivity- and precision-maximizing version (2008 revision). The
full search strategies are provided in Table S1.
Study selection and data collection process
Participants had to have a diagnosis of type 2 diabetes, be
aged 18–75 years with a BMI > 25 kg/m2, of any ethnicity,
living in any country.
Educational interventions were defined as techniques using
intellectual, physical and psychological methods resulting in
empowerment of participants, by increasing type 2 diabetes-
related knowledge and self-care behaviours for better disease
management, with a focus on weight loss. The intervention
was delivered in community settings and could be single
component providing education alone or multi-component
targeting multiple health behaviours, where education was
provided in addition to physical activity or diet or technology
or behavioural support (counselling, coaching mindfulness),
or a combination of these. Interventions were classified as
counselling interventions if it was specified that components
of the intervention were delivered by trained counsellors or
staff with specific counselling training. The main intervention
could not consist of weight loss surgery or medication.
Only randomized controlled trials (RCT) were included,
with the control or comparator group receiving usual care.
Weight and/or BMI was a main outcome of the trials and
could be presented as a primary or secondary outcome in the
trial findings. Study selection criteria are shown in Table 1.
Identified titles and abstracts were screened by two
reviewers (AM and AW) with disagreements resolved
through discussion of full-text articles and referral to a third
reviewer if necessary. Full-text articles were obtained for all
eligible trials. Multiple articles from the same trial were
grouped to prevent duplication of data (Table S2), referenc-
ing the paper presenting the weight change results. Data were
extracted from eligible trials by one reviewer (AM) and
checked by a second (AW) using standard data extraction
forms based on the TIDieR checklist [23]. Extracted data
related to participants and interventions (setting, procedures,
materials used, single or multi-component, duration, fre-
quency, intensity, tailoring or modifications, delivery, fol-
low-up, maintenance periods and outcomes). Where not
provided, weight, BMI and percentage change in weight/BMI
What’s new?
• Weight loss improves outcomes for people with type 2
diabetes. There has been considerable expansion of
related intervention research.
• This comprehensive review of 49 randomized con-
trolled trials suggests multi-component educational
interventions in community settings are effective for
weight loss in people type 2 diabetes. Education
combined with low-calorie, low-carbohydrate or low-
fat meal replacements or diets appear to achieve the
largest reduction weight and BMI.
• This study provides review-level evidence on effective
models for weight loss in people with type 2 diabetes.
When specifying and delivering these interventions,
education incorporating low-calorie, low-carbohydrate
or low-fat meal replacements should be considered.
2
ª 2019 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK
DIABETICMedicine Weight loss interventions in obese and overweight adults with type 2 diabetes  A. Maula et al.
from baseline were calculated from the data provided if
possible. Risk of bias was assessed by two independent
reviewers (AM and AW) using the Revised Cochrane
Collaboration’s risk of bias tool version 2 [24,25]. Disagree-
ments were referred to a third reviewer.
Data synthesis
Trials were classified into specified a priori comparisons
according to intervention type by two reviewers, due to the
heterogeneity between studies. It was also decided a priori by
study authors to not report an overall effect size from all
studies due to clear methodological differences between
study design and intervention types.
We estimated a pooled standardized mean difference and
95% confidence intervals (95% CI) between trial groups
from baseline to follow-up BMI and weight (difference-
in-difference) using the inverse variance method, with
random-effects terms to account for expected methodolog-
ical heterogeneity between studies. Statistical heterogeneity
was assessed by I2, given by the formula [(Q  df)/Q] 
100%, where Q is the statistic and df is the degrees of
freedom [26]. Significant statistical heterogeneity was indi-
cated by I2 > 70% and a v2 result of P < 0.01 [27].
Where available, sample sizes, mean differences in BMI
and weight change from baseline to follow-up and standard
deviations of the differences were extracted directly for each
trial group from the reported findings. If mean differences
were not reported, we calculated mean differences based on
the raw figures reported in the studies, and standard
deviation of the differences or reported confidence intervals
and standard errors of the difference where possible.
All meta-analyses were performed using Review Manager
software and presented in a forest plot; funnel plots were
provided to visually inspect evidence of asymmetry due to
small-study effects (evidence of publication bias). Where
trials had multiple intervention groups, the main intervention
group is presented in the main forest plot with additional
intervention groups presented in the Supporting Information.
Results
Study selection
The study selection process is shown in Fig. 1. Electronic
database searching identified 7383 records with an addi-
tional 49 identified through hand-searching. After removing
duplicates, 4334 records were screened for inclusion and 228
full-text articles were reviewed for eligibility. Forty-nine
trials (reported in 87 papers, Table S3) were included in the
systematic review, with 44 trials included for meta-analysis.
Study characteristics
The characteristics of included trials are described in
Table S3. Twenty-four trials were conducted in the USA
[28–50, S1] (Doc. S1); four in Germany [S2–S5] and
Australia [S6–S9]; three each in the UK [7,S10,S11] and
Sweden [S12–S14]; two each in Belgium [S15,S16], Canada
[S17,S18] and Finland [S19,S20]; and one each in India
[S21], Italy [S22], Kazakhstan [S23], New Zealand [S24] and
Spain [S25]. The 49 trials included a total of 12 461
participants. Sample sizes ranged from 27 [37] to 5145
[39]. Mean participant age ranged from 45.7 years [44] to
Table 1 Study selection criteria
Inclusion criteria Exclusion criteria
Study design
Randomized controlled trials All other study designs
Participants
Adults aged 18–75 years with a diagnosis of type 2 diabetes and overweight (BMI 25–29.9 kg/m2)
or obese (BMI > 30 kg/m2), living independently in the community (own home, warden-controlled
accommodation, extra-care/sheltered housing, retirement communities).
Participants who are pregnant or
breastfeeding, living in residential or
nursing homes or inpatients in a
secondary care setting.Participants could be of any ethnicity living in any country.
Articles written in English.
Interventions
Interventions provide diabetes related information with the aim of educating participants,
increasing knowledge levels relating to diabetes.
Weight loss surgery or where the main
intervention was weight loss
medication.Educational interventions targeting weight loss delivered in community settings, to individuals or in
groups, either face to face, telephone, email, internet, post or via smart phone apps.
Interventions may be supervised or unsupervised and individually tailored or not. Interventions may
solely target weight loss or target multiple health behaviours and include dietary modification and/
or physical activity promotion. Interventions may include behaviour change techniques such as
motivational interviewing, counselling, goal setting, self-monitoring or problem solving.
Interventions providing weight loss medication in addition to education and other interventions
were eligible.
The comparators of interest include usual care or no intervention.
Outcomes
Objectively measured body weight in kg or lbs or BMI in kg/m2. This included between-group
differences and within group differences.
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66.7 years [22] and the proportion of female participants
ranged from 0% to 100% [42]. Twenty-five trials [7,28–
32,34–38,40–50,S1,S10,S24] described the proportion of
minority ethnic participants, which ranged from 2% [7] to
100% in two trials [30,46] with exclusive Hispanic or
African-American populations.
Mean baseline BMI was reported in 46 trials, ranging from
27 kg/m2 [S21] to 39.1 kg/m2 [S18]. Two trials reported
mean baseline weight in pounds [33,45]. One trial reported a
BMI range of 27–50 kg/m2 [38].
Five trials [31,32,36,39,S18] selected participants after a
run-in phase lasting between 3 days [36] and 6 months
[S18] during which time participants confirmed their
commitment by activities such as completing food and
exercise diaries, or attending regular diabetes education
sessions.
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FIGURE 1 Selection of studies for inclusion into the review.
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Intervention description
Intervention duration ranged from 2 months [28] to
2 years [49,S9,S14,S24], most commonly lasting
12 months (n = 14 trials), with a median of 8 months.
Trials were grouped into nine intervention types (Table 2),
with education and low-calorie diets, and education and
meal replacements subdivided further. Nine trials com-
prised education alone, the remaining 40 were multi-
component.
Table 2 Characteristics of the interventions in the included trials
Intervention type Number of trials [Refs]
Education alone 9 [[33,43,44,46],S6,S10,S12,S21]
Education and counselling 3 [28,30,38]
Education and low-calorie diet
Low carbohydrate 9 [[31,47–49],S4,S9,S11,S14,S17]
Low fat 3 [S18,S20,S24]
Counselling and physical activity 3 [[36],S7,S22]
Education and modified fasting
protocol
2 [S3,S23]
Education and meal replacements
Low fat 7 [[7,29,32,34,39,50],S8]
Low carbohydrate 3 [[40],S5,S25]
Education and physical activity 4 [[35],S2,S13,S16]
Education and motivational
interviewing
1 [42]
Education and mindfulness 2 [[37],S1]
Education and coaching 3 [[41,45],S15]
Intervention deliverer Number of trials
Dietician 25
Nurse 17
Physician 14
Diabetes educator 6
Exercise physiologist 4
Nutritionist 3
Counsellor 2
Community health worker 1
Physiotherapist 1
Psychologist 2
Peer Coach 1
Not stated 5
Intervention delivered by one
professional
11 (psychologist [S16] physician [30], dietician, [[43,47,49],S17,S24] peer coach
[41] and diabetes coach/educator [[45],S1,s5])
Intervention delivered by a team 37
Unclear who delivered intervention 1 [S23]
Duration of intervention (months) Number of interventions and frequency of contacts
2 1 intervention with 2 contacts [28]
3 10 interventions, contacts ranged from 2 [S2] to 90 [45]
4 4 interventions, contacts ranged from 2 [S13] to 17 [S25]
5 2 interventions, contacts ranged from 19 [32] to 20 [46]
6 7 interventions, contacts ranged from 1 [S18] to 47 [42]
8 1 intervention with 20 contacts [29]
10 months 3 interventions, contacts ranged from 1 [S19] to 30 [48]
12 months 17 interventions, contacts ranged from 3 [30] to 54 [38]
18 months 1 intervention with 27 contacts [S7]
24 months 3 interventions with contacts ranging from 4 contacts [S14] to 21 [S9]
Tailoring of intervention
Personalized feedback Number of trials
4 provided feedback on diet [30,32,39,42]
4 provided feedback on physical activity [[28],[30],[42],S19]
3 provided feedback on weight, BMI or waist circumference [54,S15,S19]
2 provided feedback on accelerometers step count [[28],S4]
1 provided feedback on step count [S19]
4 provided feedback on glucose levels [[28,45],S15,S19]
Additional resources for
individuals not achieving weight
loss targets
Offered exercise and cooking classes, exercise equipment, food coupons or meal
replacements and weight loss medication [39]
Meal replacements, individualized dietary advice and weight loss medication [7]
Extended weight loss phase if weight loss goal not achieved. [S23,S25] or calorie
prescription adjusted if desired weight loss not being achieved [47]
Additional contacts with
intervention deliverers
5 [[38,40,45],S14,S19]
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Participant contacts were quantified in 46 trials, ranging
from one contact over 6 months [S18] to 107 contacts over
12 months [38]. Thirty trials described duration of each
contact, which ranged from 5 min [41] to 150 min [35,37,
S12]. The intervention was delivered by one educator
(n = 11 trials) or a team of educators (n = 37 trials), most
commonly dieticians, nurses and physicians. Fifteen trials
tailored the intervention by providing personalized feedback,
additional resources for those not achieving weight loss
targets, additional intervention contacts or individual tailor-
ing of the weight loss phase, which could include extending
the duration of weight loss or adjustments in calorie
prescription dependent on weight loss. Six trials had multiple
intervention groups [33,36,40,45,S6,S8]. Education was
delivered on a one-to-one basis (n = 21 trials), in group
sessions (n = 10 trials) or in individual and group sessions
(n = 17 trials); this was not specified in one trial [S21].
Education was delivered using a single mode in 35 trials; in
30 trials education was face-to-face and in five it was via
telephone. Thirteen trials used multiple modes including
face-to-face, telephone, e-mail, post, texts, online messaging
and smart phone apps. One trial did not state mode of
delivery [S21]. Additional materials were provided in 24
trials, 19 provided educational information, food menus, a
portion-controlled plate, nutrition guides or a waist circum-
ference tape measure, and 22 provided pedometers,
accelerometers, games consoles, food scales, exercise videos,
smart phone apps, glucose meters or meditation CDs.
Description of maintenance component
A maintenance intervention was delivered in seven trials,
consisting of two contacts over 3 months reviewing key
principles, participant progress and barriers to change [37].
Two contacts over 8 months, with facilitated group work
addressing facilitators and barriers [S10], and monthly
education sessions for 12 months [29,42]. Monthly face-to-
face contacts over 17 months with meal replacements
dependent on the amount of weight regained; if weight
regain was > 4 kg, full diet replacement was given for 4
weeks, weight loss medication was available [7], and at least
84 contacts over 7 years, including monthly face-to-face
contact or telephone/e-mail contact, reviewing physical
activity goals, meal replacement vouchers (one/day) and
competitions to lose weight [39]. One trial delivered coun-
selling focused on barriers to change over 3 months but did
not specify the number of contacts [33].
Risk of bias of included trials
The number of trials considered to be high risk or of some
concern for risk of bias varied across the risk of bias
domains: randomization process, n = 32; deviations from the
intended interventions, n = 37; missing outcome data,
n = 19; measurement of the outcome, n = 5; and selection
of reported result, n = 39. Overall, all trials were found to be
at high risk or some concern of risk of bias. However, it
would not have been possible to blind participants, inter-
vention deliverers or outcome assessors to treatment group
allocation in most behaviour change trials and this has had a
negative impact on the assessment of overall trial quality
(Table S4 and Fig. S1).
Measurements of treatment effect
Outcome data were reported at the end of the intervention in
20 trials; the remaining trials reported data at multiple time
points (Table S5).
Forty-one trials reported weight or change in weight from
baseline, 26 trials reported BMI or change in BMI from
baseline, and 18 trials reported both weight and BMI or
changes from baseline. Outcome reporting varied between
trials, including within-group change from baseline,
between-group differences in weight/BMI or between-group
differences in change from baseline. Details on primary and
secondary outcomes for each trial are given in Table S3.
Weight and BMI
Fifteen trials saw a < 5% between-group difference for
weight loss favouring the intervention group at the end of the
trial, six achieved a 5–10% difference and three achieved
> 10% weight loss difference between groups from baseline
favouring the intervention group (Fig. 2a). Those achieving
the greatest weight loss difference between groups were two
low-carbohydrate trials (education, low-calorie and educa-
tion, meal replacements) and a trial with a modified fasting
regime.
Six trials saw a < 5% difference between groups for BMI
reduction favouring the intervention group, five trials saw a
5–10% difference and two saw a >10% difference in BMI at
the end of the intervention favouring the intervention group
(Fig. 2b). Those achieving the greatest BMI differences
between groups favouring the intervention group of > 10%
were both carbohydrate-restricted interventions, one was an
education, low-calorie, low-carbohydrate diet and another
utilized a low-carbohydrate meal replacement.
All five trials pre-selecting participants showed significant
effects on weight/BMI [31,34,36,39,S18]. All five trials
providing extra contacts with intervention staff, if required,
saw significant effects on weight [38,40,45,S14,S19]. Eight of
the nine trials providing personalized feedback showed
significant effects on weight/BMI [28,32,39,42,45,S4,S15,
S19].
Trials reporting no significant effects on weight or BMI
Thirteen trials found no significant between- or within-group
difference in weight and/or BMI or change in weight and/or
BMI from baseline [30,35,41,44,47–49,S1,S6,S9,S12,S16,
S24]. These trials typically provided minimal contact time
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with interventionists, with five trials having on average fewer
than one contact per month [30,44,S6,S12,S24]. Four trials
with predominantly minority ethnic populations (87% [44],
94% [41] and 100% [30,S1]) failed to find significant effects
on weight/BMI favouring the intervention group.
Trials with prolonged follow-up but no maintenance
intervention
Ten trials [32,47,S5,S7,S8,S15,S16,S20,S23,S24] had a pro-
longed follow-up period in which no maintenance
intervention was delivered. This ranged from 6 months [32,
S7,S16,S23] to 18 months [S8].
Two trials showed significant between-group differences at
the end of the intervention [S7,S15]; however, at 6- and 12-
month follow-up the results became non-significant. One
trial continued to show significant between-group difference
in change in weight from baseline at the end of the follow-up
at 12 months [32] and one trial continued to show significant
change in weight and BMI from baseline at 12 months [S5].
One of the six trials [S16] did not find a significant reduction
in weight/BMI. Two trials did not present data for the end of
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FIGURE 2 Trials reporting significant between-group differences in (a) weight loss and (b) BMI reduction. Edu: education, PA: physical activity, low
cal: low calorie, low carb: low carbohydrate, counsel: counselling, mod fast: modified fasting, meal replace: meal replacements, mot interview:
motivation interviewing
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the follow-up period [47,S23], and one combined interven-
tion and control group data at the end of the intervention
and follow-up periods [S8].
Meta-analyses of trials
All meta-analyses are reported in Figs S2 and S3 grouped into
12 a priori comparisons of standardized mean differences
(SMD) (BMI reported in kg/m2, weight in kg) between
baseline and follow-up between intervention and control
groups (difference-in-difference).
Education alone
There were nine trials of education alone, eight of which could
be synthesized in the meta-analyses. The ninth trial lacked
control group data [S21]. Four trials were conducted in the
USA [33,43,44,46], with one each in Australia [S6], Finland
[S19], Sweden [S12] and the UK [S10]. Sample sizes ranged
from 48 [S19] to 241 [S6]. Duration of interventions ranged
from 3 months [33] to 12 months [44,43,S6,S12,S19].
Pooled results show education alone reduced weight
significantly (SMD –0.63, 95% CI –1.00 to –0.26, n = 5
studies; I2 = 60%), but not BMI (SMD –0.87, 95% CI –1.83
to 0.09, n = 4 studies; I2 = 86%).
Education and counselling
Three trials of education and counselling were included
within the meta-analysis; all were conducted in the USA
[28,30,38]. Sample size ranged from 52 [28] to 563 [38].
Duration of intervention was 2 months [28] or 12 months
[30,38].
Pooled results show that education and counselling did not
significantly reduce weight (SMD –0.73, 95% CI –1.89 to
0.42, n = 3 studies; I2 = 98%). In a single trial, education
and counselling also did not significantly reduce BMI (SMD –
0.66, 95% CI –1.32 to 0.00, n = 1 study; I2 = not available).
Education and a low-calorie, low-carbohydrate diet
Nine trials had interventions consisting of education and a
low-calorie, low-carbohydrate diet, eight of which were
included in the meta-analyses. One trial [49] did not report
standard deviations.
Three trials were from the USA [31,47,48], with one each
from Australia [59], Canada [S17], Germany [S4], Sweden
[S14] and the UK [S11]. Sample size ranged from 61 [S14] to
115 [S9]. Duration of intervention ranged from 3 months
[S11] to 24 months [S9,S14].
Pooled results showed education and a low-calorie, low-
carbohydrate diet significantly reduced weight (SMD –1.25,
95% CI –2.11 to –0.39, n = 8 studies; I2 = 96%) and BMI
(SMD –1.32, 95%CI –3.71 to 1.08, n = 3 studies; I2 = 95%).
Education and a low-calorie, low-fat diet
Three trials were included; one each in Canada [S18],
Finland [S20] and New Zealand [S24]. Sample sizes ranged
from 86 [S20] to 419 [S24]. Duration of intervention ranged
from 6 months [S18] to 24 months [S24].
Pooled results show education, low-calorie and a low-fat
diet significantly reduced weight (SMD –0.44, 95% CI –0.61
to –0.27, n = 2 studies; I2 = 0%) and BMI in a single trial
(SMD –1.00, 95% CI –1.46 to –0.54, n = 1 study; I2 = not
available).
Education, low-calorie diet, counselling and physical activity
A single trial from Italy [S22] with 30 participants, and
intervention length of 3 months was included. Other trials
lacked change from baseline data [S7] and lack of standard
deviation data in the control group [36]. The results show
education, low-calorie diet, counselling and physical activity
did not significantly reduce weight (SMD –0.34, 95%CI –1.06
to 0.39, n = 1 study; I2 = not available) in this single study.
Education and modified fasting
Two trials were included within the meta-analysis, one from
Germany with 46 participants over 4 months [S3] and one
from Kazakhstan [S23] with 272 participants over 6 months.
The latter showed much greater reductions in weight and
BMI in the intervention group than in the control group,
most likely accounting for the large SMD values.
The pooled results showed that education and modified
fasting did not significantly reduce weight (SMD –3.54, 95%
CI –9.85 to 2.78, n = 2 studies; I2 = 100%) or BMI (SMD –
1.86, 95% CI –4.14 to 0.43, n = 2 studies; I2 = 92%).
Education and low-calorie, low-fat meal replacements
Therewere seven trials. Six from theUSA [29,32,34,39,40,50]
and one from the UK [7]. Sample sizes ranged from 49 [7]
to 5145 [39]. Intervention length ranged from 3 months
[34] to 24 months [7]. One trial was excluded as it lacked
control group data from baseline. [S8]
Pooled results show that education and low-calorie, low-fat
meal replacements significantly reduced weight (SMD –1.15,
95% CI –1.41 to –0.89, n = 7 studies; I2 = 82%) and BMI
(SMD –1.57, 95%CI –2.05 to –1.09, n = 3 studies; I2 = 85%).
Education and low-calorie, low-carbohydrate meal
replacements
Three trials were included in the meta-analysis; one from
each of Germany [S5], Spain [S25] and the USA [40]. Sample
size ranged from 89 [S25] to 227 [40] with intervention
duration ranging from 3 months [S5] to 12 months [40].
Pooled results show education and low-calorie, low-
carbohydrate meal replacements significantly reduced weight
(SMD –2.48, 95% CI –3.79 to –1.16, n = 3 studies;
I2 = 96%) and BMI (SMD –2.54, 95% CI –3.59 to –1.49,
n = 3 studies; I2 = 98%).
Education and physical activity
Four trials were included; one from each of Belgium [S16],
Germany [S2], Sweden [S13] and the USA [35]. Sample size
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ranged from 50 [S13] to 220 [S2]. Intervention duration
ranged from 3 months [35,S2] to 6 months [S16].
Pooled results show that education and physical activity
did not significantly reduce weight (SMD –0.14, 95% CI –
0.35 to 0.07, n = 3 studies; I2 = 0%) or BMI (SMD –0.14,
95% CI –0.34 to 0.05, n = 4 studies; I2 = 0%).
Education and motivational interviewing
There was one trial from the USA [42] with 217 participants
conducted over 6 months. In this trial, education and
motivational interviewing reduced weight significantly
(SMD –0.33, 95% CI –0.60 to –0.06, n = 1 study; I2 = not
available).
Education and mindfulness
Two trials were included, both from the USA. One had 52
participants with an intervention over 3 months [37] and the
other had 111 participants conducted over 12 months [S1].
Pooled results showed that education and mindfulness did
not significantly reduce weight (SMD 0.99, 95% CI –2.16 to
4.13, n = 2 studies; I2 = 98%). In one trial, the intervention
actually increased BMI significantly (SMD 0.51, 95% CI
0.40 to 0.62, n = 1 study; I2 = not available).
Education and coaching
There were three trials on education and coaching. One from
Belgium [S15] and two from the USA [41,45]. Sample size
ranged from 221 [45] to 574 [S15], with intervention length
ranging from 3 months [45] to 10 months [41].
Pooled results showed that education and coaching did not
significantly reduce weight (SMD –0.19, 95% CI –0.61 to
0.23, n = 2 studies; I2 = 82%) or BMI (SMD –0.12, 95% CI
–0.76 to 0.52, n = 2 studies; I2 = 85%).
Publication bias
Funnel plots are visually symmetrical showing limited effects
of publication bias (Fig. S4).
Maintenance
Seven trials [7,29,33,37,39,42,S10] contained a maintenance
component. Three reported significant between-group effects
in weight/BMI at the end of the intervention and mainte-
nance periods favouring the intervention group [7,39,42].
Two trials reported significant change in weight from
baseline at the end of both the intervention and maintenance
periods in the intervention groups [29,37]; one of the two
trials [37] also showed a significant change from baseline in
the control group at the end of the maintenance period that
was larger than that in the intervention group. All five trials
reported some regain of weight/BMI during the maintenance
period, with change in weight from baseline reducing from
10% to 7.2% [7], 8.6% to 4.7% [39], 4.8% to 3.6% [42],
7.1% to 5.5% [29] and 1.7% to 1.4% [37] at the end of the
intervention and maintenance periods, respectively.
Discussion
Main findings
To our knowledge, this is the largest contemporary review
assessing the evidence for educational weight loss interven-
tions in obese or overweight individuals with type 2 diabetes.
This meta-analysis has shown that 6 of 12 intervention
categories were significantly effective for weight loss. The
most effective interventions were: education, low-calorie,
low-carbohydrate meal replacements, –2.48 [–3.79, –1.16];
followed by education, low-calorie low-carbohydrate diet,
–1.25 [–2.11, –0.39]; education, low-calorie, low-fat meal
replacements, –1.15 [–1.41, –0.89]; education alone, –0.63
[–1.00, –0.26]; education with a low-calorie and low-fat diet,
–0.44 [–0.61, –0.27]; and finally education and motivational
interviewing, –0.33 [–0.60, –0.06].
For BMI reduction, 3 of 12 intervention categories were
significantly effective. Education, low-calorie, low-carbohy-
drate meal replacement was most effective, –2.54 [–3.59,
–1.49], with education, low-calorie, low-fat meal replace-
ments the second most effective, –1.57 [–2.05, –1.09],
followed by education and a low-calorie, low fat diet,
–1.00 [–1.46, –0.54].
Meal replacements, specifically low-carbohydrate followed
by low-fat varieties, and then low-calore, low-carbohydrate
diets appeared the most effective tools for reducing weight, a
low-fat diet in meal replacements or alone as a low-calorie
diet appeared to be less effective when compared with a low-
carbohydrate comparison.
Non-significant groups of interventions within the meta-
analysis may have been due to significant heterogeneity,
small sample sizes, small number of trials within each
category and low-quality studies.
Five trials with a maintenance intervention (3 months to 7
years) showed significant weight reduction or change in
weight/BMI at both the end of the intervention and main-
tenance periods, with weight regain during the maintenance
phases.
Comparison with existing literature and explanations
Our findings suggest that trials containing low-calorie meal
replacements or diets in combination with education had the
greatest effect, consistent with previous reviews, showing
multi-component intensive interventions containing low-
calorie diets were the most effective for weight loss [20].
Meal replacements have also been found to achieve greater
weight loss in people without diabetes compared with
portion- or calorie-restricted diets [S26–S29]. Obese individ-
uals may underestimate calorie consumption when consum-
ing conventional foods [34,S28] even when given a daily
calorie limit, and meal replacements avoid this. Recent trials
show remission of diabetes in 58% of participants on a low-
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carbohydrate diet [S30]. A recent review and meta-analysis
found ‘little to no difference’ between low-carbohydrate and
low-fat diets on metabolic control [S31]. A second recent
meta-analysis found that compared with high-carbohydrate
interventions, low-carbohydrate diets had the greatest effect
on metabolic control within the first year of the intervention
with no effect on weight [S32].
We found that interventions containing personalized
feedback (individualized advice to each participant based
on diet, physical activity, weight/BMI, step counts and
glucose levels) were associated with significant weight loss.
In people without diabetes, short-term individualized feed-
back on fitness and health may influence an individual’s
awareness of their behaviour [S33]. Another review sug-
gested a positive impact on weight loss for internet-delivered
interventions of < 12 months’ duration providing personal-
ized feedback in overweight and obese individuals [S34]. We
note that trials containing a pre-selection [32,36,39,S29]
component (where participants had to confirm commitment
to the intervention by completing self-monitoring activities
lasting 3–28 days, or attending regular educational sessions
over a 6-month period) all showed significant weight
reductions. These trials may be recruiting those who are
ready and motivated to change, and their findings may be less
generalizable to the wider population of adults with type 2
diabetes.
Strengths and limitations
We have identified more trials than preceding systematic
reviews in this field, yielding data for a greater number of
participants We also identified more trials showing greater
mean weight loss favouring the intervention group than in
previous reviews [19–21]. Although 22 trials in this review
reported significant between-group changes, only seven
provided actual values for between-group differences.
The majority of included trials had predominantly
Caucasian populations, who were mostly middle-aged,
range 45.7 years [44] to 66.7 years [S22], and were
conducted in high-income countries. This may limit gener-
alizability to other ethnic groups, low- or middle-income
countries, and the younger or older. Indeed, those trials
including the highest proportions of Black and minority
ethnic communities failed to find significant effects on
weight/BMI. We may have missed some weight loss trials
where overweight was defined as a BMI > 23 kg/m2, as
seen in Indian and Asian populations. We also note that 18
trials had fewer than 100 participants, so may have had
limited power to detect smaller, but clinically important,
weight/BMI reductions.
The larger mean baseline BMI in the most successful trials
may have led to an overestimation of the effect of the
intervention as they comprised participants with potential for
greater weight loss. There were limited trials available in
those who were severely obese, with no trial having a mean
weight of participants > 40 kg/m2, limiting generalizability
in this context. Trial findings were not always well reported,
with some not presenting data at all time points [36] and
others not reporting statistical significance of all findings
[S21]. In addition, it is difficult to disentangle the effect that
intervention participants current antidiabetic medications
may have on weight loss.
The interventions were analysed according to intervention
type; however, the provision of education varied within
individual trials with some delivered one-to-one, others to
groups, face-to-face or via internet or telephone contact. A
range of different healthcare professionals were used to
deliver the education. This may all have an impact on
diabetes self-care behaviours and adherence to the interven-
tion affecting the outcome measure.
The meta-analysis has several limitations including a
diverse range of types of educational interventions and small
numbers of trials for each type of intervention. In addition,
many trials had a small number of participants affecting
power. We also included trials of any duration in our review.
This may have an effect on short-term results of the
intervention on weight/BMI loss, as it is known that weight
loss maintenance is problematic for the majority of people
after participating in weight loss programmes. Twenty-eight
of the 49 trials identified (57%) had interventions lasting less
than 12 months. The results of these interventions maybe of
limited significance to clinical practice as the long-term
success of these interventions to weight and BMI change in
uncertain.
There was substantial heterogeneity among the included
trials, with weight ranging from I2 = 0% to I2 = 100% and
BMI ranging from I2 = 0% to I2 = 99%, this means that the
findings should be interpreted with caution. This hetero-
geneity was predicted based on the varying trial designs,
sociodemographic characteristic of participants, culture and
geography of the interventions affecting healthcare provision
as well as variations in outcome measures and methods of
analysis used (between- or within-group comparisons).
There was a risk of performance and ascertainment bias in
nearly all the trials, however, this is difficult to mitigate due
to the nature of the behaviour change intervention. It is
possible that future trials may alter the conclusions drawn
from this review.
Implications for research, policy and practice
Our review highlights the importance of diet in type 2
diabetes for weight loss. Educational weight loss interven-
tions incorporating low-calorie meal replacements appear to
be the most effective weight loss tools. The trials in our
review used meal replacements ranging from once daily to
three times daily over 4–52 weeks. Recent evidence suggests
prolonged or repeated use of meal replacements may have
negative effects on gut microbial diversity, which may be
associated with, but not limited to immune-mediated
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diseases including inflammatory bowel diseases, irritable
bowel syndrome and colorectal cancers [S35–S37]. Our
findings provide review-level evidence to support the design
of community-based programmes using meal replacements,
which are increasingly the focus of national initiatives such
as that in the UK of a community-based weight loss
programme comprising 3 months of meal replacements and
behavioural support for people with type 2 diabetes [7,S38,
S39].
Our review also showed that maintenance interventions
can be effective in helping prevent weight regain and these
need to be incorporated into any weight loss intervention.
However, there remains a need to improve lifestyle mainte-
nance interventions.
Further trials are needed in Black and minority ethnic
populations [S40,S41], particularly given the greater preva-
lence of, and poorest outcomes from type 2 diabetes in these
groups [S40,S42]. Finally, trials that provide a better
understanding of why specific interventions do, or do not
work for particular population groups are also required.
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